ChemicalBook > Product Catalog >Organic Chemistry >Heterocyclic Compounds >3-Quinuclidinyl benzilate

3-Quinuclidinyl benzilate

3-Quinuclidinyl benzilate Basic information
Product Name:3-Quinuclidinyl benzilate
Synonyms:1-Azabicyclo(2.2.2)octan-3-ol, benzilate;1-azabicyclo(2.2.2)octan-3-ol,benzilate;1-Azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate;3-(2,2-diphenyl-2-hydroxyethanoyloxy)-quinuclidine;3-Chinuclidylbenzilate;3-Hydroxyquinuclidine benzilate;3-Oxyquinuclidine benzilate;3-Quinuclidinol benzilate
CAS:6581-06-2
MF:C21H23NO3
MW:337.42
EINECS:233-250-6
Product Categories:
Mol File:6581-06-2.mol
3-Quinuclidinyl benzilate Structure
3-Quinuclidinyl benzilate Chemical Properties
Melting point 164.5°C
Boiling point 473.72°C (rough estimate)
density 1.1644 (rough estimate)
refractive index 1.5614 (estimate)
storage temp. 2-8°C
solubility chloroform: but decomposes within 24 hrssoluble
pka11.28±0.29(Predicted)
form powder
color white
CAS DataBase Reference6581-06-2
NIST Chemistry Reference3-Quinuclidinyl benzilate(6581-06-2)
EPA Substance Registry SystemBenzeneacetic acid, .alpha.-hydroxy-.alpha.-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester (6581-06-2)
Safety Information
Hazard Codes Xn,T+
Risk Statements 22-26
Safety Statements 28-36/37-45
WGK Germany 3
RTECS DD4638000
HS Code 29333910
Hazardous Substances Data6581-06-2(Hazardous Substances Data)
ToxicityLD50 intraperitoneal in mouse: 103mg/kg
MSDS Information
ProviderLanguage
SigmaAldrich English
3-Quinuclidinyl benzilate Usage And Synthesis
DescriptionThe 3-quinuclidinyl benzilate (3-QNB) was first discovered by Hoffmann-La Roche in 1951 during research investigation that involved development of antispasmodic agents, resembling atropine, for treating gastrointestinal conditions. Soon after, the US Army investigated 3-QNB under the name of EA2277 agent and was standardized for use in chemical munitions in 1961 under the name agent of BZ. The United States declared complete destruction of its stockpile of BZ by 1989. Moreover, Agent 15 is speculated either to be identical to BZ or a closely related derivative, and has similar physicochemical properties as BZ. In 1998, Agent 15 was speculated to be stockpiled by Iraq but later on intelligence reports did not find any conclusive evidence for such claim1. The BZ is a glycolate anticholinergic chemical related to atropine, scopolamine, and, hyoscyamine. It is odorless, nonirritating, and is stable in most solvents. It has a half-life of 3–4 weeks in moist air and is extremely persistent in soil, water, and most surfaces. BZ has a slow onset and a long duration-of-action. The rate of BZ action climaxed after 9.5 h of exposure and the duration-of-action could last up to 96 h. Moreover, most of the causalities of BZ exposure will require physical restraint and continuous monitoring to prevent self-injury and paranoia symptoms during recovery2. Recent speculation about the usage of Agent 15 in Syrian civil war had been reported but no confirmation findings had been established3.
Chemical PropertiesColourless solid
Uses3-quinuclidinyl benzilate(BZ) is a nonlethal chemical warfare agent that following a delayed onset is incapacitating and causes severe hallucinations. US Army intended to use BZ in critical point situations such as special operation, incapacitating adversaries during raid, and overcoming fortified field positions. Medically, BZ is used as a muscarinic receptor antagonist.
General DescriptionColorless liquid, odorless to fruity.
Environmental FateBZ acts by blocking the action of acetylcholine on the central and peripheral nervous systems. It is a tertiary amine and crosses the blood–brain barrier. BZ on acute exposure increases both heart and respiratory rates, dilates the pupils, and causes paralysis of the eye muscles necessary for near focusing. It also causes dry mouth and skin, elevates body temperature, impairs coordination, and causes flushing of the skin, hallucinations, stupor, forgetfulness, and confusion.Within 15 min to 4 h following exposure, the principal effects are dizziness, involuntary muscle movements, near vision difficulty, and total incapacitation. From 6 to 10 h after exposure, the effects are psychotropic and full recovery is expected after 4 days.
The peripheral nervous system effects are considered as understimulation of the end organs. This decreased stimulation of eccrine and apocrine sweat glands in the skin results in dry skin and a dry mouth, and is considered ‘dry as a bone.’ The reduction in the ability to dispel heat by evaporative cooling decreases sweating, and the compensatory cutaneous vasodilation causes the skin to become warm or ‘hot as a hare’ and ‘red as a beet.’ This is similar to the atropine flush. The decreased heat loss also results in an increased core temperature.
Toxicity evaluationQNB-BZ or Agent 15 has been tested on different surfaces by the US Army Medical Research Institute of Chemical Defense and the overall conclusion was that QNB-BZ persists as a parent molecule for an extended period of time reaching 72 h4.
3-Quinuclidinyl benzilate Preparation Products And Raw materials
Tag:3-Quinuclidinyl benzilate(6581-06-2) Related Product Information
Quinine dihydrochloride Glatiramer acetate Davercin Ammonium acetate Ethyl acetate CHLOROPHOSPHONAZO III CYCLANDELATE Vinyl acetate Sodium acetate Tocopheryl acetate QUINUCLIDINE Quinine sulfate dihydrate ACETATE Benzilic acid Clidinium bromide 3-Quinuclidinyl benzilate Glycolic acid 3-Quinuclidinol